Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC)

被引：0

作者：

Emanuele Vita

Alessio Stefani

Geny Piro

Luca Mastrantoni

Marco Cintoni

Giuseppe Cicchetti

Ileana Sparagna

Federico Monaca

Guido Horn

Jacopo Russo

Diletta Barone

Mariantonietta Di Salvatore

Rocco Trisolini

Filippo Lococo

Ciro Mazzarella

Alessandra Cancellieri

Carmine Carbone

Anna Rita Larici

Maria Cristina Mele

Sara Pilotto

Michele Milella

Giampaolo Tortora

Emilio Bria

机构：

[1] Fondazione Policlinico Universitario Agostino Gemelli IRCCS,UOSD Oncologia Toraco

[2] Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Polmonare, Comprehensive Cancer Center

[3] Università Cattolica del Sacro Cuore,UOC Oncologia Medica, Comprehensive Cancer Center

[4] Fondazione Policlinico Universitario Agostino Gemelli IRCCS,UOC Nutrizione Clinica

[5] Fondazione Policlinico Universitario Agostino Gemelli IRCCS,UOC Radiologia Toracica e Cardiovascolare, Advanced Radiodiagnostics Center

[6] Fondazione Policlinico Universitario Agostino Gemelli IRCCS,UOC Pneumologia Interventistica

[7] Fondazione Policlinico Universitario Agostino Gemelli IRCCS,UOC Chirurgia Toracica

[8] Fondazione Policlinico Universitario Agostino Gemelli IRCCS,UOC Radioterapia Oncologica

[9] Fondazione Policlinico Universitario Agostino Gemelli IRCCS,UOC Anatomia Patologica

[10] Verona University Hospital Trust,UOC Oncologia Medica

来源：

Cancer Immunology, Immunotherapy | 2023年 / 72卷

关键词：

SCLC; Immunotherapy; Metabolomics; Leptin; Adipokines; Obesity;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：3803 / 3812

页数：9

共 49 条

[41] A Prognostic Scoring Model to Determine Which Patients with Metastatic Extensive-stage Small Cell Lung Cancer Could Benefit from Local Radiotherapy: a Large Population-based Study [J].

Shan, Qinge ;

Li, Zhenxiang ;

Lin, Jiamao ;

Wang, Zhehai ;

Wang, Haiyong .

DISCOVERY MEDICINE, 2019, 27 (150) :255-265

[42] Efficacy and safety of immunotherapy or antiangiogenic agent-based treatment strategies versus chemotherapy as first-line treatment for extensive-stage small cell lung cancer: a network meta-analysis [J].

Wang, Chengjun ;

Yang, Chuang ;

Zhao, Wen ;

Zhang, Rongyu ;

Xuan, Tiantian ;

Li, Jisheng .

FRONTIERS IN PHARMACOLOGY, 2025, 16

[43] Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE study [J].

Thomas, M. ;

Ponce-Aix, S. ;

Navarro, A. ;

Riera-Knorrenschild, J. ;

Schmidt, M. ;

Wiegert, E. ;

Kapp, K. ;

Wittig, B. ;

Mauri, C. ;

Gomez, M. Domine ;

Kollmeier, J. ;

Sadjadian, P. ;

Froehling, K. -P. ;

Huber, R. M. ;

Wolf, M. ;

Pall, Georg ;

Surmont, Veerle ;

Bosquee, Leon ;

Germonpre, Paul ;

Brueckl, Wolfgang ;

Grah, Christina ;

Herzmann, Christian ;

Leistner, Rumo ;

Meyer, Andreas ;

Mueller, Lothar ;

Schmalz, Oliver ;

Scholz, Christian ;

Schroeder, Michael ;

Serke, Monika ;

Wesseler, Claas ;

Brandts, Christian ;

Kopp, Hans-Georg ;

Blau, Wolfgang ;

Griesinger, Frank ;

Garcia Campelo, Maria Rosario ;

Garcia Garcia, Yolanda ;

Trigo Perez, Jose Manuel .

ANNALS OF ONCOLOGY, 2018, 29 (10) :2076-2084

[44] Treatment-related Adverse Events, Including Fatal Toxicities, in Patients With Extensive-stage Small-cell Lung Cancer Receiving Adjuvant Programmed Cell Death 1/Programmed Cell Death Ligand 1 Inhibitors: A Meta-analysis and Trial Sequential Analysis of Randomized Controlled Trials [J].

de Moraes, F. C. A. ;

Lobo, A. de O. M. ;

Sano, V. K. T. ;

Kelly, F. A. ;

Burbano, R. M. R. .

CLINICAL ONCOLOGY, 2024, 36 (10) :E408-E419

[45] Development and validation of a nomogram for assessing survival in extensive-stage small-cell lung cancer patients with superior vena cava syndrome referred for thoracic radiotherapy: a comparison of upfront vs. consolidative approaches [J].

Mei, Ting ;

Xiu, Weigang ;

Yang, Xuexi ;

Tian, Xiaoman ;

Yu, Yang ;

Xu, Yong ;

Zhou, Lin ;

Zhou, Xiaojuan ;

Liu, Yongmei ;

Zou, Bingwen ;

Xue, Jianxin ;

Ao, Rui ;

Lu, You ;

Gong, Youling .

STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (12) :1072-1083

[46] East Asian patients who received immunotherapy-based therapy associated with improved survival benefit in advanced non-small cell lung cancer: An updated meta-analysis [J].

Yao, Yueyuan ;

Li, Butuo ;

Xu, Yiyue ;

Yang, Linlin ;

Zou, Bing ;

Wang, Linlin .

CANCER MEDICINE, 2024, 13 (04)

[47] The impact of smoking status on the progression-free survival of non-small cell lung cancer patients receiving molecularly target therapy or immunotherapy versus chemotherapy: A meta-analysis [J].

Li, Xinyi ;

Huang, Cong ;

Xie, Xiaohui ;

Wu, Ziyang ;

Tian, Xia ;

Wu, Yibo ;

Du, Xin ;

Shi, Luwen .

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (02) :256-266

[48] Effects of traditional Chinese medicine combined with chemotherapy for extensive-stage small-cell lung cancer patients on improving oncologic survival: study protocol of a multicenter, randomized, single-blind, placebo-controlled trial [J].

Chen, Yuyi ;

Yu, Mingwei ;

Liu, Zishen ;

Zhang, Yi ;

Li, Qiwei ;

Yang, Guowang .

TRIALS, 2021, 22 (01)

[49] No survival benefit with early incorporation of thoracic radiotherapy using daily fractionation in patients with limited-stage small cell lung cancer undergoing chemoradiotherapy in the modern era: A systematic review and meta-analysis [J].

Kim, Byoung Hyuck ;

Song, Changhoon ;

Kim, Hak Jae .

RADIOTHERAPY AND ONCOLOGY, 2023, 184

← 1 2 3 4 5 →